Financial intelligence for Asia's healthcare markets
 
 
Remember me:


News articles    

Health-focused insurance start-up CXA Group has raised $25 million in its latest round of funding.
The healthcare market in Asia-Pacific is expected to grow by 7.2% this year due to the growth of smart hospitals and developments in the home care segment and medical tourism.
Global private equity firms, including KKR, CVC and Carlye, are reported to be be bidding for Columbia Pacific Management’s Asian hospital business, Columbia Asia Group.
Hong Kong-based Baring Private Equity Asia is set to acquire AGS Health, a medical revenue cycle management company for $320 million.
Triple Ten, a multi-national holding company based in Hong Kong, has invested in C-BeyondHealth, a US product development company specialising in medicinal cannabinoid products.
Everlife, private equity firm Everstone Capital’s pan-Asian healthcare platform, has invested in in-vitro diagnostics (IVD) products manufacturer CPC Diagnostics, enabling the company to take its product portfolio to new markets and customers.
The Hong Kong government is to set up a public healthcare stabilisation fund using a $10 billion cut of the 2019 budget to further support the public healthcare sector, finance secretary Paul Chan Mo-po has announced.
India’s Life Insurance Council is to ask the Insurance Regulatory and Development Authority of India to reinstate its right to sell indemnity health cover, which allows policyholders to reclaim money after visiting a doctor.
Major international and local insurance companies are joining Hong Kong’s big new private medical coverage initiative, introduced to relieve pressure from the territory’s overburden public health system.
Aged care provider and health insurer Bupa has paid the Australian tax office A$157 million after settling a long-running dispute.
12345678910...

Subscribe to our news RSS feed Get the RSS for HealthInvestor Asia



Civica

AON


Markets

The IPO market in Hong Kong is hotting up again and it looks as though 2019 is going to be as busy with biotech company floats as last year was.


Podcasts

Analysis

HealthInvestor Asia twitter feed



Podcasts

HealthInvestor UK